China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Evaluation of the Efficacy and Safety of Ruxolitinib Phosphate Cream in the Treatment of Rosacea'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136119
Registration Time: 2026/11/05
Type: Interventional study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349131
Published by HT Digital Content Services with permission from Health Daily Digest....